SCHEMBL3845263

SCHEMBL3845263

CN(C)c1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncnc(-c4ccc(S(C)(=O)=O)s4)c3c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 12/20 0.34
CYP3A4 P08684 12/20 0.34
ALDH1A1 P00352 8/20 0.34
MAPK1 P28482 8/20 0.34
CYP2D6 P10635 8/20 0.34
CYP2C19 P33261 7/20 0.34
TSHR P16473 6/20 0.34
HSD17B10 Q99714 5/20 0.34
HPGD P15428 5/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 3/20 0.34
HIF1A Q16665 3/20 0.34
CASP1 P29466 2/20 0.34
HBB P68871 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
RAF1 P04049 2/20 0.34
CLK4 Q9HAZ1 7/20 0.34
LMNA P02545 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846261 0.91 CA12 (0.34) CYP1A2CYP3A4ALDH1A1CYP2D6CYP2C19
SCHEMBL3853047 0.91 CA12 (0.32) CYP1A2CYP3A4ALDH1A1MAPK1CYP2D6
SCHEMBL3854489 0.91 PTGS2 (0.35) CYP1A2CYP3A4MAPK1CYP2D6CYP2C19
SCHEMBL3855222 0.90 CYP1A2 (0.34) CYP1A2CYP3A4ALDH1A1CYP2D6CYP2C19
SCHEMBL3854275 0.90 CYP3A4 (0.33) CYP1A2CYP3A4ALDH1A1MAPK1CYP2D6
SCHEMBL3851760 0.89 MAP4K4 (0.33) CYP1A2CYP3A4ALDH1A1MAPK1CYP2D6
SCHEMBL3847026 0.89 STK17B (0.32) CA12CA1CA2CA9
SCHEMBL3855022 0.89 PAX8 (0.36)
SCHEMBL3849245 0.88 MAP4K4 (0.33) CYP1A2CYP3A4ALDH1A1MAPK1HSD17B10
SCHEMBL3849354 0.87 SCN9A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed